Syneos Health Reports Third Quarter 2022 Results
November 04, 2022 06:10 ET
|
Syneos Health, Inc.
Revenue for the third quarter of $1,336.2 million decreased 0.9% on a reported basis and increased 2.2% on a constant currency basis year-over-year.Clinical Solutions net new business awards and...
Syneos Health Appoints William E. Klitgaard Independent Director
October 14, 2022 16:45 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of William E....
Syneos Health Wins Triangle Business Journal 2022 Leaders in Diversity Award
October 13, 2022 07:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it has been awarded a Triangle...
Syneos Health Releases Annual Sustainability Report
October 05, 2022 07:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 2021 Sustainability Report....
Syneos Health Leaders Recognized by HBA
May 10, 2022 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 10, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Kasey Boynton, MPH, MBA,...
Syneos Health Promotes Baba Shetty to President, Technology and Data Solutions, and Suma Ramadas to Executive Vice President, Medical Affairs
April 19, 2022 08:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 19, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the promotions of two senior...
Syneos Health Releases 2022 Dealmakers’ Intentions Survey
January 11, 2022 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 12th annual Dealmakers’...